Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin K Jackson

Showing results (61-70 of 263) with videos related to

Pageof 27
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cellsBradley T Andresen, Guillermo G Romero, Edwin K Jackson
Clinical and Experimental Pharmacology & Physiology|November 2, 2007
Cellular distribution of the renal bumetanide-sensitive Na-K-2Cl cotransporter BSC-1 in the inner stripe of the outer medulla during the development of hypertension in the spontaneously hypertensive ratPrajakta A Sonalker, Stevan P Tofovic, Edwin K Jackson
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cellsRaghvendra K Dubey, Delbert G Gillespie, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2015
Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMPJonathan D Verrier, Patrick M Kochanek, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2007
Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive ratsEdwin K Jackson, Mingdi Zhang, Weili Liu, et al.
Clinical and Experimental Pharmacology & Physiology|April 9, 2010
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndromeDavid S Tofovic, Victor P Bilan, Edwin K Jackson
Texas Heart Institute Journal|December 27, 2011
Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran useMervyn B Forman, Paul G Sutej, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2020
DPP4 Inhibition, NPY<sub>1-36</sub>, PYY<sub>1-36</sub>, SDF-1<i>α</i>, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-MethoxyestradiolEdwin K Jackson, Delbert G Gillespie, Stevan P Tofovic
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2003
Cardiovascular pharmacology of estradiol metabolitesRaghvendra K Dubey, Stevan P Tofovic, Edwin K Jackson
Steroids|June 9, 2004
A gas chromatography/mass spectrometry assay to measure estradiol, catecholestradiols, and methoxyestradiols in plasmaLefteris C Zacharia, Raghvendra K Dubey, Edwin K Jackson
Pageof 27

Showing results (61-70 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cellsBradley T Andresen, Guillermo G Romero, Edwin K Jackson
Clinical and Experimental Pharmacology & Physiology|November 2, 2007
Cellular distribution of the renal bumetanide-sensitive Na-K-2Cl cotransporter BSC-1 in the inner stripe of the outer medulla during the development of hypertension in the spontaneously hypertensive ratPrajakta A Sonalker, Stevan P Tofovic, Edwin K Jackson
Hypertension (Dallas, Tex. : 1979)|March 8, 2002
A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cellsRaghvendra K Dubey, Delbert G Gillespie, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2015
Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMPJonathan D Verrier, Patrick M Kochanek, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|August 30, 2007
Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive ratsEdwin K Jackson, Mingdi Zhang, Weili Liu, et al.
Clinical and Experimental Pharmacology & Physiology|April 9, 2010
Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndromeDavid S Tofovic, Victor P Bilan, Edwin K Jackson
Texas Heart Institute Journal|December 27, 2011
Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran useMervyn B Forman, Paul G Sutej, Edwin K Jackson
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2020
DPP4 Inhibition, NPY<sub>1-36</sub>, PYY<sub>1-36</sub>, SDF-1<i>α</i>, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-MethoxyestradiolEdwin K Jackson, Delbert G Gillespie, Stevan P Tofovic
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2003
Cardiovascular pharmacology of estradiol metabolitesRaghvendra K Dubey, Stevan P Tofovic, Edwin K Jackson
Steroids|June 9, 2004
A gas chromatography/mass spectrometry assay to measure estradiol, catecholestradiols, and methoxyestradiols in plasmaLefteris C Zacharia, Raghvendra K Dubey, Edwin K Jackson
Pageof 27